Reference
NICE. Breast cancer patients to have routine access to two life extending drugs after new deal, say NICE in draft guidance Internet Document : 16 Nov 2017. Available from: URL: https://www.nice.org.uk/news/article/breast-cancer-patients-to-have-routine-access-to-two-life-extending-drugs-after-new-deal-say-nice-in-draft-guidance
Rights and permissions
About this article
Cite this article
NICE recommends palbociclib and ribociclib for breast cancer. PharmacoEcon Outcomes News 792, 35 (2017). https://doi.org/10.1007/s40274-017-4558-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4558-7